Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion

Ceftazidime/Avibactam and Meropenem/Vaborbactam for the Management of Enterobacterales Infections: A Narrative Review, Clinical Considerations, and Expert Opinion

This comprehensive review examines the unique attributes, distinctions, and clinical implications of ceftazidime–avibactam (CAZ-AVI) and meropenem–vaborbactam (MEM-VAB) against difficult-to-treat <i>Enterobacterales</i> infections. Our manuscript explores these antibiotics’ pharmacokinet...

Full description

Bibliographic Details
Main Authors: Andrea Marino, Edoardo Campanella, Stefano Stracquadanio, Maddalena Calvo, Giuseppe Migliorisi, Alice Nicolosi, Federica Cosentino, Stefano Marletta, Serena Spampinato, Pamela Prestifilippo, Stefania Stefani, Bruno Cacopardo, Giuseppe Nunnari
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Antibiotics
Subjects:
ceftazidime–avibactam
meropenem–vaborbactam
carbapenem-resistant <i>Enterobacterales</i>
carbapenemases
Gram-negative infections
new BL/BLICs
Online Access:https://www.mdpi.com/2079-6382/12/10/1521

Internet

https://www.mdpi.com/2079-6382/12/10/1521

Similar Items